跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUVITRU - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CUVITRU
Authorized
STANDARD
CUVITRU
takeda canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ac6787a8ad35ca92
Company
takeda canada inc
Type
Standard
Approval Details
Approval Id
ac6787a8ad35ca92
Drug Approval Canada Name
CUVITRU
Product Name
CUVITRU
Status
Marketed
Status Date
2021-12-03
Original Market Date
2017-12-21
Din
02461692
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D
Ahfs
80:04.00
Atc Original
J06BA01 IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASC. ADM
Atc Name
j 06 ba 01
Aig Number
0106267011
Company Name
takeda canada inc
Company Address
3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3
Active Ingredients
IMMUNOGLOBULIN (HUMAN)
200 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ac6787a8ad35ca92
Type
Standard
Back to Health Canada Approvals